Compare FVRR & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FVRR | SLDB |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.3M | 498.6M |
| IPO Year | 2019 | 2017 |
| Metric | FVRR | SLDB |
|---|---|---|
| Price | $10.53 | $8.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $18.43 | $16.36 |
| AVG Volume (30 Days) | 722.9K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,094,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.83 | N/A |
| P/E Ratio | $22.05 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.67 | $2.45 |
| 52 Week High | $34.13 | $8.69 |
| Indicator | FVRR | SLDB |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 61.59 |
| Support Level | $10.25 | $5.16 |
| Resistance Level | $11.26 | $8.47 |
| Average True Range (ATR) | 0.44 | 0.63 |
| MACD | 0.19 | 0.08 |
| Stochastic Oscillator | 70.25 | 77.04 |
Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.